New vaccine for influenza virus H1N1 : Pharmacosurveillance of adverse reactions in health staff at Hospital San Luis, Argentina

In March 2010, the Immunization Program of San Luis Province began a vaccination campaign against influenza A H1N1 with monovalent and trivalent vaccines. Being this the first year that this vaccine is used, and following the recommendations of WHO, we decided to develop pharmacovigilance actions in...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sarmiento, María G., Ballerino Montacci, Elisabeth S., Collado, Jesica A., Videla, Natalia, Avila, Alicia N.
Formato: Articulo Comunicacion
Lenguaje:Inglés
Publicado: 2011
Materias:
Farmacia
Virus de la Influenza A
farmacovigilancia
Vacunas
Acceso en línea:http://sedici.unlp.edu.ar/handle/10915/8352
http://www.latamjpharm.org/resumenes/30/8/LAJOP_30_8_2_4.pdf
Aporte de:
SEDICI (UNLP) de Universidad Nacional de La Plata
id I19-R120-10915-8352
record_format dspace
institution Universidad Nacional de La Plata
institution_str I-19
repository_str R-120
collection SEDICI (UNLP)
language Inglés
topic Farmacia
Virus de la Influenza A
farmacovigilancia
Vacunas
spellingShingle Farmacia
Virus de la Influenza A
farmacovigilancia
Vacunas
Sarmiento, María G.
Ballerino Montacci, Elisabeth S.
Collado, Jesica A.
Videla, Natalia
Avila, Alicia N.
New vaccine for influenza virus H1N1 : Pharmacosurveillance of adverse reactions in health staff at Hospital San Luis, Argentina
topic_facet Farmacia
Virus de la Influenza A
farmacovigilancia
Vacunas
description In March 2010, the Immunization Program of San Luis Province began a vaccination campaign against influenza A H1N1 with monovalent and trivalent vaccines. Being this the first year that this vaccine is used, and following the recommendations of WHO, we decided to develop pharmacovigilance actions in order to assess its safety. Our objective was to identify, describe and analyze adverse reactions associated with the vaccine against pandemic influenza occurring in health personnel of the Hospital San Luis, through active monitoring of vaccinated employees. An epidemiological descriptive and transversal study was carried out from March to June 2010. We found that 67 % (n = 809) reported adverse reactions associated with the vaccine. Main adverse reactions reported included: pain at injection site (54 %), fatigue, swelling and redness, malaise, headache and fever. The most frequent adverse reactions that have been reported were non-serious and within expectations.
format Articulo
Comunicacion
author Sarmiento, María G.
Ballerino Montacci, Elisabeth S.
Collado, Jesica A.
Videla, Natalia
Avila, Alicia N.
author_facet Sarmiento, María G.
Ballerino Montacci, Elisabeth S.
Collado, Jesica A.
Videla, Natalia
Avila, Alicia N.
author_sort Sarmiento, María G.
title New vaccine for influenza virus H1N1 : Pharmacosurveillance of adverse reactions in health staff at Hospital San Luis, Argentina
title_short New vaccine for influenza virus H1N1 : Pharmacosurveillance of adverse reactions in health staff at Hospital San Luis, Argentina
title_full New vaccine for influenza virus H1N1 : Pharmacosurveillance of adverse reactions in health staff at Hospital San Luis, Argentina
title_fullStr New vaccine for influenza virus H1N1 : Pharmacosurveillance of adverse reactions in health staff at Hospital San Luis, Argentina
title_full_unstemmed New vaccine for influenza virus H1N1 : Pharmacosurveillance of adverse reactions in health staff at Hospital San Luis, Argentina
title_sort new vaccine for influenza virus h1n1 : pharmacosurveillance of adverse reactions in health staff at hospital san luis, argentina
publishDate 2011
url http://sedici.unlp.edu.ar/handle/10915/8352
http://www.latamjpharm.org/resumenes/30/8/LAJOP_30_8_2_4.pdf
work_keys_str_mv AT sarmientomariag newvaccineforinfluenzavirush1n1pharmacosurveillanceofadversereactionsinhealthstaffathospitalsanluisargentina
AT ballerinomontaccielisabeths newvaccineforinfluenzavirush1n1pharmacosurveillanceofadversereactionsinhealthstaffathospitalsanluisargentina
AT colladojesicaa newvaccineforinfluenzavirush1n1pharmacosurveillanceofadversereactionsinhealthstaffathospitalsanluisargentina
AT videlanatalia newvaccineforinfluenzavirush1n1pharmacosurveillanceofadversereactionsinhealthstaffathospitalsanluisargentina
AT avilaalician newvaccineforinfluenzavirush1n1pharmacosurveillanceofadversereactionsinhealthstaffathospitalsanluisargentina
bdutipo_str Repositorios
_version_ 1764820488691908610

Ejemplares similares